June 2, 2010 ·
Leave a comment
Paul Meade, a 25-year veteran of the pharmaceutical industry, founded Thought Leader Select in 2006. Throughout his career, Paul served in several leadership positions in sales, marketing, and strategic planning, culminating in his role of director of worldwide commercial development for predictive medicine at GlaxoSmithKline.
After leaving GSK, Paul launched two companies, Clear Point Health, in 2005, and Thought Leader Select, in 2006. Paul’s work with these two companies entails marketing planning, consulting for research and development and clinical operations, as well as his breakthrough work with medical expert collaborations for the pharmaceutical industry.
The Thought Leader Select Blog sat down with Paul to discuss his industry experience and his professional contribution to Thought Leader Select.
TLS Blog: Good afternoon, Paul. Why did you start Thought Leader Select?
Paul Meade: About a year before starting the company, I had begun consulting with the health industry with my partner, Lisa Smith, through our company, Clear Point Health. We were taking on a number of projects, working with medical affairs teams, marketing teams, and research and development groups within the industry.
One of our large clients came to me and told me that, even though they’d been working with thought leaders for over ten years, they realized how little they really knew about them. When they sat down to consolidate all of their knowledge about their medical ... read more »
May 11, 2010 ·
Leave a comment
May 11, 2010 (CHAPEL HILL, NC) Paul Meade, founder and president of Thought Leader Select, a North Carolina firm dedicated to key opinion leader (KOL) development solutions for the biopharmaceutical industry, received a master of public health degree from the University of North Carolina at Chapel Hill on May 8, 2010.
The Gillings School of Global Public Health at UNC awarded Meade, a 25-year veteran of the pharmaceutical industry, with a master of public health degree and a certificate in public health ethics in the Public Health Leadership Program. Meade’s research report, “How Volunteer Community Organizations Can Assist State Public Health Departments During Pandemic Influenza,” explored specific possibilities for the Civil Air Patrol, a volunteer non-profit national organization and an auxiliary of the United States Air Force, to assist state public health officials during widespread outbreaks of influenza.
The master of public health degree is Meade’s second master’s degree. He earned a master of science in biomedical science from the University of Guelph (Canada) in 1977, following his bachelor of science degree in biology and chemistry from Acadia University (Canada) in 1971.
During his 25-year career in the pharmaceutical industry, Meade served in a variety of leadership positions at Merck and GlaxoSmithKline. During his ten years at Merck, Meade worked his way from a sales representative position to director of marketing planning for ... read more »
April 15, 2010 ·
Dr. Maher “Max” Noureddine joined Thought Leader Select as its chief scientific officer in 2007, after a two-year stint as a senior research fellow in molecular genetics at the National Institute of Environmental Health Sciences/National Institutes of Health (NIEHS/NIH). Prior to his time at the NIEHS/NIH, Max conducted post-doctoral research in Parkinson’s disease at Duke University Medical Center from 2002-2005. In 2002, Max earned a PhD in biology from the University of North Carolina at Chapel Hill. During his career, Max has co-authored 13 published research studies and presented his research findings at 13 conferences.
The Thought Leader Select Blog recently sat down to catch up with Max Noureddine and learn about his background and how he makes his professional contribution to the work of Thought Leader Select.
TLS Blog: Thanks for agreeing to an interview with your busy schedule, Max. Why did you join Thought Leader Select in 2007?
Max: I was at a critical juncture of my career, finishing up my post-doctoral work at Duke in the field of Parkinson’s disease. Basically, I was weighing up my career alternatives, which normally would mean that someone with my academic and scientific background would head straight into university teaching and research.
I had gotten to know Paul Meade, the founder of the company, since we were both pilots in the Civil Air Patrol together. ... read more »